Playlist

Coworking “Telwas”: A Modern Space for Work, Study, and Business Meetings

28 Aug. 03:41

The world is changing rapidly, and along with it, the approaches to work, education, and human interaction are transforming as well. Today, coworking spaces are becoming an essential part of modern office culture — especially in the era of digitalization, online learning, and remote work.

“Telwas” Coworking is a workspace that meets the current demands of the time and offers comfortable solutions for a wide range of activities.

It’s a convenient place for freelancers to work, for holding online meetings, studying, launching startups, and presenting new products. To support this, “Telwas” provides:

  • Private cabins for talking with family or participating in online classes;

  • Comfortable workspaces for freelancers and remote employees;

  • Areas for presentations and seminars, where entrepreneurs can showcase their projects or products to potential partners and clients.

Even companies with their own offices increasingly choose coworking centers for meetings and events — since not every office is equipped for presentations or business negotiations.

“Telwas” creates a space where you can not only work, but also develop ideas, meet like-minded people, and advance your projects.

The fast pace of modern life demands flexibility — and “Telwas” delivers that flexibility.

Address: Gurtly Residential Complex, Building 110
Phone: 970790
Instagram: @telwas.koworking

“Telwas” Coworking — where every moment works for results.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌